Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Nucleic Acids Research|February 25, 1989
Dual enhancer activities of the cyclic-AMP responsive element with cell type and promoter specificityC Kanei-Ishii, S IshiiBlood Cells, Molecules & Diseases|August 14, 2001
Regulation of c-Myb activity by tumor suppressor p53J Tanikawa, E Ichikawa-Iwata, C Kanei-Ishii, et al.The Journal of Biological Chemistry|June 3, 1994
c-Myb-induced trans-activation mediated by heat shock elements without sequence-specific DNA binding of c-MybC Kanei-Ishii, T Yasukawa, R I Morimoto, et al.Oncogene|June 1, 1992
Transcriptional activation of the c-myc gene by the c-myb and B-myb gene productsH Nakagoshi, C Kanei-Ishii, T Sawazaki, et al.The Journal of Biological Chemistry|February 25, 1990
Binding of the c-myb proto-oncogene product to the simian virus 40 enhancer stimulates transcriptionH Nakagoshi, T Nagase, C Kanei-Ishii, et al.Science (New York, N.Y.)|July 11, 1997
Activation of heat shock transcription factor 3 by c-Myb in the absence of cellular stressC Kanei-Ishii, J Tanikawa, A Nakai, et al.Oncogene|April 21, 2001
Constitutive c-Myb amino-terminal phosphorylation and DNA binding activity uncoupled during entry and passage through the cell cycleA Cures, C House, C Kanei-Ishii, et al.The Journal of Biological Chemistry|October 27, 1995
Increase of solubility of foreign proteins in Escherichia coli by coproduction of the bacterial thioredoxinT Yasukawa, C Kanei-Ishii, T Maekawa, et al.The Tohoku Journal of Experimental Medicine|October 1, 1992
Transcriptional control by myb oncogene productS Ishii, T Nomura, C Kanei-Ishii, et al.Oncogene|September 1, 1991
Transformation by carboxyl-deleted Myb reflects increased transactivating capacity and disruption of a negative regulatory domainY L Hu, R G Ramsay, C Kanei-Ishii, et al.Pageof 2